Detection of Escherichia coli O157:H7 and O104:H4 in patients with diarrhea in Northern Lebanon and characterization of fecal E.coli producing ESBL and carbapenemase genes by Amrieh, Sara et al.
The InTernaTIonal arabIc Journal 
of anTImIcrobIal agenTs    Issn 2174-9094
© Under License of Creative Commons Attribution 3.0 License 1
2014
Vol. 4 No. 3:4
doi: 10.3823/756
iMedPub Journals
http://journals.imed.pub
This article is available from: www.iajaa.org   /   www.medbrary.com
Detection of Escherichia coli 
O157:H7 and O104:H4 in patients 
with diarrhea in Northern 
Lebanon and characterization of 
fecal E. coli producing ESBL and 
carbapenemase genes
1  Health and Environmental Microbiology 
Laboratory (LMSE), AZM Center for 
Research in Biotechnology, Doctoral 
School of Science and Technology, 
Lebanese University, Tripoli - Lebanon.
2  Faculty of Public Health, Lebanese 
University, Tripoli - Lebanon.
3  NINI Hospital Laboratory, Tripoli - 
Lebanon
Corresponding author:
Prof. Dr. Monzer HAMZE
mhamze@monzerhamze.com
Sara Amrieh1, Monzer 
Hamze1,2*, Hassan 
Mallat1,2, Marcel Achkar3, 
Fouad Dabboussi1,2
Abstract
Background. While most strains of Escherichia coli (E. coli) are harm-
less, some are causing intestinal infections of varying severity. The 
Shiga toxin-producing E. coli (STEC)/ enterohemorrhagic E. coli strains 
can be associated with fatal clinical manifestations. Of these E. coli Se-
rotypes O157: H7 and O104: H4 were responsible for worldwide epidem-
ics causing thousands of intestinal infections and dozens of deaths. 
The aim of this research is to investigate the prevalence of E. coli O157: 
H7 and O104: H4 in the diarrheal stools of 242 Lebanese patients.
Materials and methods. This study includes 242 E. coli strains isolated 
from fecal specimens of patients with diarrhea between February 
2013 and May 2014 in the microbiology department of Nini Hospital 
Laboratory in Tripoli - North Lebanon. All specimens were inoculated 
on sorbitol MacConkey agar. Sorbitol negative strains were investi-
gated for detection of stx1, stx2 and eae genes using real-time PCR. 
All carbapenem-resistant strains and ESBL producers were investigated 
by PCR for presence of KPC, IMI, NMC-A, EMS, GHG, VIM, NDM, IMP, 
OXA-48, blaTEM, blaCTX-M, blaSHV, blaOXA, blaGES and blaPER..
Results. A total of 14 sorbitol negative strains were detected. The 
search for stx1, stx2 and eae genes showed the presence of a single 
positive strain for E. coli O157: H7. Out of 242 E.coli strains, 48 (19.8%) 
were ESBL-positive, 4 (1.6%) were resistant to ertapenem, and all were 
negative for stx2 genes, The blaCTX-M gene was the most frequent 
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among ESBL positive strains (85%), followed by the blaTEM gene (50%). 
One strain had the blaNDM-1 gene, another had the blaOXA-48 gene and 
2 strains were probably resistant due to impermeability.
Conclusion. The results of this study demonstrate rarely presence of 
enterohemorrhagic E. coli, but shows the frequent presence of multi-
drug resistant E.coli in the intestinal flora of North Lebanese patients. 
Therefore, it is important to search for MDR E.coli in the intestinal 
flora of patients who are going to be treated with major operations 
or those admitted to intensive care units.
Keywords: E. coli O157:H7, E. coli O104:H4, resistance to carbapenems.
Introduction
There are about 1.7 billion cases of diarrhea each 
year worldwide. It was considered the second cause 
of mortality in children under five years of age and 
was responsible for 760.000 child deaths per year 
according the report of WHO in 2013 [1]. Rotavirus 
and E. coli are the two most common causes of 
diarrhea in developing countries [1]. The majority 
of E. coli strains are commensal organisms, how-
ever, some were associated with intestinal and 
extra-intestinal diseases. Among these, the Shiga 
toxins producing E. coli (STEC)/enterohemorrhagic 
E. coli (EHEC) strains which are a major cause of 
bacterial gastroenteritis in the world [2]. There are 
six pathotypes of intestinal E. coli described in lit-
erature, associated with acute diarrheal disease on 
the basis of their expressed virulence factors; ETEC 
“enterotoxigenic E. coli,” EPEC “enteropathogenic 
E coli, “EHEC” enterohaemorrhagic E. coli, “EIEC” 
enteroinvasive E. coli, “EAggEC” enteroaggrega-
tive E. coli, and “DAEC” diffusely adhering E. coli 
[3]. Infection with an EHEC strains can take various 
clinical forms ranging from asymptomatic carriage 
to fatal infection. The most common clinical mani-
festation is Hemorrhagic Colitis (HC) which can be 
progressed to Hemolytic Uremic Syndrome (HUS), 
or Thrombotic Thrombocytopenic Purpura (TTP) es-
pecially in children and the elderly patients[4]. EHEC 
O157: H7 is the serotype most important to public 
health but other serotypes have been frequently 
involved in sporadic cases and outbreaks [5, 6]. 
During May- June 2011, a large outbreak of E. coli 
enteroaggregative Hemorrhagic (EAHEC) O104: H4 
was reported in Germany and led to HUS in more 
than 800 patients, many of whom were adults, and 
ultimately resulted in 54 deaths [6, 7]. The severity 
of this outbreak was significantly higher due to the 
serotype O104: H4 with over 20% cases of HUS and 
1.4% of deaths than with other the serotype O157: 
H7. Those HUS cases were affected mainly young 
children with a mortality rate of 0.5% [8]. While it 
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is recognized that commensal fecal bacteria were 
important in the emergence of resistance under an-
tibiotic selection pressure. Recently, the main threat 
is the spread of bacteria with resistant to carbapen-
ems in intestinal of people, since carbapenems are 
currently the only cure for many serious infections 
caused by multidrug-resistant (MDR) bacteria [9].
This research aimed to investigate the prevalence 
of E. coli O157 and E. coli O104 in stools of patients 
with diarrhea in Northern Lebanon by detection 
their virulence genes stx1, stx2 and eae using real 
time PCR . Also at the same time to evaluate the 
rate of fecal E.coli isolates producing ESBL and car-
bapenems- resistant.
Materials and methods
Place and period of the study
This study carried out over the period March 25, 
2014 and August 8, 2014 in the microbiology labo-
ratory, health and environment, at the Azm research 
center for biotechnology which is part of the gradu-
ate doctoral school of the Lebanese University.
Fecal E.coli isolates
A total of 242 fecal specimens of diarrheal patients 
were sent to Microbiology Department of Nini Hospi-
tal Laboratory in Tripoli - North Lebanon. All specimens 
were cultured on sorbitol MacConkey agar (Conda®-
Spain); the culture plates were incubated for 24 hours 
at 37 °C. All E.coli isolates were identified by the Api 
20E gallery (Biomérieux®-France) according to the 
protocol suggested by the manufacturer.
Screening for EHEC O157: H7 strains
All sorbitol negative E.coli isolates were investi-
gated for stx1, stx2 and eae genes using real-time 
PCR utilizing ready to use kits (“Foodproof® STEC 
Screening LyoKit”( BIOTECON Diagnostics Gmbh – 
Germany).
Determination of positive ESBL strains 
and/or resistant to carbapenems
For the detection of ESBL type resistance and/or 
the presence of carbapenems resistance, we fol-
lowed the recommendations of the Antibiogram 
Committee of the French Society of Microbiology 
- 2014 (CA-SFM, 2014) [10]. For each strain show-
ing resistance to ertapenem or an ESBL profile 
using antibiotic susceptibility by the disc method on 
Muller-Hinton agar (Biorad®, France) according to 
the recommendations of the CA-SFM -2014. [10] 
Finally, the Hodge test was performed for strains 
resistant to ertapenem [11].
Determination of resistance by production 
of cephalosporinase.
The inhibition tests are based on the increase in the 
diameter of inhibition around a disc combining a car-
bapenem (meropenem or imipenem) and a specific 
inhibitor of β-lactamases. By testing bacteria produc-
ing beta-lactams on a medium containing cloxacillin 
(250 mg/l) (cephalosporinase inhibitor) and compara-
tively on a medium without cloxacillin, we can detect 
a resistance to carbapenems not related to the pro-
duction of carbapenemase but to the association of 
cephalosporinase and by default the accumulation of 
carbapenems which results in a significant increase of 
the inhibition diameters on the first medium .
Molecular Study of carbapenems resistant 
strains 
A total of 4 E.coli carbapenem-resistance isolates 
were examined for presence the genes of KPC, IMI, 
NMC-A, EMS, GHG, VIM, NDM, IMP and OXA-48 
(Table 1). Each isolate is cultivated on nutrient agar 
(Biorad®, France) and incubated for 24 hours at 
37ºC. Few colonies of each isolates were suspend-
ed in 0.5 ml of ultrapure sterile water, their DNA 
were extraction using the kit “GenEluteTM Bacte-
rial Genomic DNA Kit, Sigma-Aldrich.”.and stored at 
-20 °C. The PCR was performed using the following 
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protocol: 12.5μl Mix (REDTaq® ReadyMixTM PCR re-
action mix with MgCl2. Sigma – Aldrich - Germany) 
was mixed with 5.5 μl of ultrapure water, 5 μl of 
plasmid extract, and 2 μl of each primer. The mix-
ture was incubated in a thermo cycler. PCR products 
were analyzed by electrophoresis in 1% agarose gel 
to visualize the amplicon bands .
Molecular studies of ESBL strains
A total of 48 E.coli producing ESBL isolates were 
tested for the following beta-lactamse genes: blaTEM, 
blaCTX-M, blaSHV, blaOXA, blaGES and blaPER (Table 1). 
The same protocol described above was applied.
Table 1. The different primer sequences for each carbapenemase and ESBL 
gene and the PCR corresponding conditions.
 
Genes Sequence
Amplicon size 
(pb)
Reference
blaKPC F
blaKPC R
ATGTCACTGTATCGCCGTCT
TTACTGCCCGTTGACGCCC
882 [12]
blaSME F
blaSME R
ACTTTGATGGGAGGATTGGC
ACGAATTCGAGCATCACCAG
551 [13]
blaIMI-NMC 
F
blaIMI-NMC 
R
TGCGGTCGATTGGAGATAAA
CGATTCTTGAAGCTTCTGCG
399 [13]
blaGES F
blaGES R
CTATTACTGGCAGGGATCG
CCTCTCAATGGTGTGGGT
594 [14]
blaVIM F
blaVIM R
GATGGTGTTTGGTCGCATA
CGAATGCGCAGCACCAG
170 [15]
blaIMP F
blaIMP R
GAGTGGCTTAATTCTCRATC
AACTAYCCAATAYRTAAC
120 [14]
blaNDM-1F
blaNDM-1R
GGTGCATGCCCGGTGAAATC
ATGCTGGCCTTGGGGAACG
660 [16]
blaOXA-48 F
blaOXA-48 R
GGGGACGTTATGCGTGTATT
GAGCACTTCTTTTGTGATGGC
900 [17]
blaTEM-F
blaTEM-R
ATGAGTATTCAACATTTCCG
CTGACAGTTACCAATGCTTA
867 [18]
blaSHV-F
blaSHV-R
GGTTATGCGTTATATTCGCC
TTAGCGTTGCCAGTGCTC
867 [18]
blaOXA-F
blaOXA-R
ACACAATACATATCAACTTCGC
AGTGTGTTTAGAATGGTGATC
885 [18]
blaCTX-MU1
blaCTX-MU2
ATGTGCAGYACCAGTAARGT
TGGGTRAARTARGTSACCAGA
593 [18]
blaGES-A
blaGES-B
CTTCATTCACGCACTATTAC
TAACTTGACCGACAGAGG
827 [18]
blaPER-A
blaPER-B
GGGACARTCSKATGAATGTCA
GGGYSGCTTAGATAGTGCTGAT
827 [18]
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Detection of EHEC O104 strains among 
ESBL positive strains
Positive isolates for Stx2 (lp43, lp44) gene was de-
tected using conventional PCR for ESBL positive 
strains according to Bielaszewska et al. [6].
Results
Out 242 of E. coli isolates, 14 strains were sorbi-
tol negative (5.78%). Of these only one isolate was 
positive for stx1, stx2 and eae genes.  This isolate 
was isolated from a twenty year-old girl hospital-
ized for severe diarrhea and the search for presence 
of Salmonella, Shigella and the Rotavirus antigen 
was negative. The isolate was susceptible to all an-
tibiotics routinely tested for enteric bacteria in the 
laboratory.
All ESBL-positive E. coli isolates were negative for 
stx 2 gene (Table 2).  
The distribution of ESBL 6 genes (blaTEM, blaCTX-M, 
blaSHV, blaOXA, blaGES and blaPER)  are shown in Ta-
ble 3.
The resistance profile of the carbapenems-resistant 
E.coli isolates is shown in Ttable 2. Of the 4 iso-
lates resistant to ertapenem, 2 were positive for the 
Hodge test, one had the blaOXA-48 gene and the 
Table 2. Antibiotics sensitivity profile of ESBL and 
carbapenems resistant strains
Carbapenems 
resistant 
strains
Antibiotic
% of 
Sensitivity 
(ESBL strains)
1 2 3 4
Cefoxitin 81.2 R R R R
Cefepime 8.3 I R R R
Piperacillin-
Tazobactam
79.1 R R R R
Ticarcillin-
Clavulanate
52.0 R R R R
Cefotaxime 0 R R R R
Amoxicillin-
Clavulanate
62.5 R R R R
Ceftazidime 0 R R R R
Ticarcillin 2.0 R R R R
Cefixime 0 R R R R
Aztreonam 2.0 I R R R
Cefuroxime 0 R R R R
Piperacillin 0 R R R R
Ertapenem 95.8 R R R R
Imipenem 97.9 S R S R
Meropenem 95.8 S R S R
Ampicillin 0 R R R R
Amikacin 97.9 S S S S
Netilmycin 77.0 R S S I
Colistin 100 S S S S
Trimetroprim-
Sulfamtoxazole
37.5 R R R R
Tobramycin 60.4 R R R R
Gentamicin 66.6 R S R R
Ofloxacin 58.3 R R R R
Ciprofloxacin 62.5 R R R R
Nalidixic acid 27.0 R R R R
Tigecyclin 97.9 S S S S
Minocyclin 77.0 S R R S
Tetracyclin 43.7 S R R R
Fosfomycin 97.9 S S S S
Table 3. Results of ESBL genes characterization
Genes types No (%) Strains  
blaTEM 24 (50)
blaCTX-M 41 (85.4)
blaOXA 3 (6.2)
blaSHV 0
blaPER 0
blaGES 0
blaTEM-blaCTX-M 17 (35.4)
blaOXA-blaCTX-M 3 (6.2)
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other had the blaNDM-1 gene. The other 2 isolates 
were negative for the Hodge test and negative for 
all the ESBL genes. 
Discussion
According to the surveillance unit of enteric com-
municable diseases in Lebanon, a report issued in 
2012 showed high occurrence rate of typhoid fever 
(426cases). The report also observed high incidence 
of food poisoning (319 cases) and 176 dysentery 
cases [19]. The prevalence of E. coli O157: H7 and 
E. coli O104: H4 among diarrheagenic cases is still 
unknown in Northern Lebanon. Stool cultures are 
routinely not culture to detect enterohaemorrhagic 
E. coli in Lebanon, and searching for this organism is 
only done if requested by the physician. Our results 
showed a rare presence of E. coli O157: H7 (0.4%), 
(one isolates out 242 diarrhea cases), and there is 
no single E. coli O104 isolate. A similar result was 
reported recently in Jordan [ 20 ]. In Iraq, one study 
reported a prevalence of 11.5% for EHEC O157: H7 
in the stool of 200 children with hemorrhagic diar-
rhea [21]. About 93% of E. coli strains of human 
origin ferment sorbitol in 24 hours; conversely E. coli 
O157 does not ferment sorbitol [22], but other study 
reported that some STEC O157 strains may ferment 
sorbitol within 24 hours [23]. The emergence of the 
epidemic strain EAHEC O104: H4 depends on the ac-
quisition of prophage stx2 and a plasmid encoding 
ESBL (CTX-M-15) [24]. That is why we looked for 
the presence of the stx 2 gene in all ESBL positive 
E. coli, the results were negative. The EAHEC O104: 
H4 has caused a major epidemic of diarrhea cases 
during 2011 in Germany, where 3842 patients in-
fected and 855 cases developed HUS [7]. Another 
small outbreak was reported in France during June 
2011 [25]. 
The present study shows that 19.8% of E.coli iso-
lates from fecal specimens of Lebanese patients 
with diarrhea were ESBL-producers .This result is 
similar to other recent reported studies from other 
continents . For example a study from Argentina in 
2012, showed that the carrier rate of ESBL-positive 
E. coli strains in the fecal flora was 17.0% [26], 
while the study from Libya in 2014, demonstrated 
the prevalence of ESBL-producing E. coli at 13.4% 
[27]. In addition, our study indicated that blaCTX-
M gene was predominant (85%), followed by the 
blaTEM (50%) and blaOXA (6%) genes, whereas the 
blaSHV, blaPER and blaGES were absent in our E.coli 
isolates. A French study showed a predominance of 
the blaCTX-M gene (86%) followed by the blaSHV gene 
in E. coli strains isolated from fecal flora (14%) [28], 
while a Spanish study detected less rate of ESBL-
producing E. coli in stool samples of healthy males 
from in 2007 [29]. 
It is important to note that almost all ESBL-producing 
E.coli isolates were susceptible to amikacin (97.9%), 
to less extent to cefoxitin and piperacillin-tazobac-
tam combination, and with high rate of resistance 
to fluoroquinolones (Table 2). In Egypt, a study 
reported in 2009, that ESBL-positive E. coli strains 
isolated from the fecal flora have resistance rate of 
39.4% to fluoroquinolones and 11.9% to amikacin, 
while all were susceptible to carbapenems [30]. A 
Jordanian study reported recently that MDR E.coli 
isolates from feces of infants accounted for 30.6%, 
and all were ESBL producers. The detection rate 
of CTX-M genes among these isolates was 94.2%, 
and CTX-M group 1 accounted for 87.8% of the 
isolates, and 73.2% were CTX-M-15 producers [31].
This study shows that few E.coli isolates (4) were 
resistant to ertapenem, including one strain carried 
blaNDM-1 gene and another strain has the blaOXA-48 
gene. A previous study by Beyrouthy et al. in Leba-
non reported on the prevalence of carbapenems-
resistant among Enterobacteriaceae in the fecal 
flora of healthy children. The study showed that 
3/183 investigated E.coli strains were resistant to er-
tapenem, all carried blaOXA-48 gene, and their study 
suggests that blaOXA-48 has become endemic in 
Northern Lebanon [32]. In China, the prevalence of 
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carbapenems-resistant among Enterobacteriaceae 
in the fecal flora of hospitalized patients was 6.6% 
(20/303 patients), of which 8 isolates were carried 
blaKPC-2, blaIMP-4 and blaNDM-1 and typed as carbap-
enemase producers [33]. Another study conducted 
in South Korea, showed that the carrier rate of car-
bapenems-resistant fecal E.coli strains was 1.44% 
(5/347) [34].
In conclusion, our results shows the importance of 
investigation continuously the fecal stools of pa-
tients for prevalence of MDR E.coli and other enteric 
bacteria, particularly it is necessary to characterize 
the ESBL type resistance genes including gene se-
quencing of carbapenems and perform molecular 
epidemiological studies by pulsed field gel electro-
phoresis.
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